ATE306497T1 - Peptid für die diagnose und therapie von tumoren - Google Patents
Peptid für die diagnose und therapie von tumorenInfo
- Publication number
- ATE306497T1 ATE306497T1 AT03025866T AT03025866T ATE306497T1 AT E306497 T1 ATE306497 T1 AT E306497T1 AT 03025866 T AT03025866 T AT 03025866T AT 03025866 T AT03025866 T AT 03025866T AT E306497 T1 ATE306497 T1 AT E306497T1
- Authority
- AT
- Austria
- Prior art keywords
- tumors
- peptide
- diagnosis
- therapy
- motif
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 238000003745 diagnosis Methods 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 208000023958 prostate neoplasm Diseases 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03025866A EP1531159B1 (de) | 2003-11-11 | 2003-11-11 | Peptid für die Diagnose und Therapie von Tumoren |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE306497T1 true ATE306497T1 (de) | 2005-10-15 |
Family
ID=34429327
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03025866T ATE306497T1 (de) | 2003-11-11 | 2003-11-11 | Peptid für die diagnose und therapie von tumoren |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1531159B1 (de) |
| AT (1) | ATE306497T1 (de) |
| DE (1) | DE60301891T2 (de) |
| WO (1) | WO2005044842A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1714978A1 (de) * | 2005-04-19 | 2006-10-25 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Peptide zur Diagnose und Therapie von Tumoren |
| WO2012016713A1 (en) * | 2010-08-05 | 2012-02-09 | Ruprecht-Karls-Universität Heidelberg | Tumour targeting with polypeptides |
| EP2744483B1 (de) | 2011-08-15 | 2020-04-29 | Jyant Technologies | Freisetzungssystem für spezifisches targeting von krebszellen und verwendungsverfahren dafür |
| CN103204904B (zh) * | 2013-02-01 | 2015-07-22 | 浙江海洋学院 | 一种抗前列腺癌赤魟软骨蛋白多肽及其制备方法和用途 |
| CN105079817B (zh) * | 2014-05-20 | 2018-05-18 | 中国人民解放军第二军医大学 | 靶向前列腺癌的药物递送载体、递送系统及其制备与应用 |
-
2003
- 2003-11-11 DE DE60301891T patent/DE60301891T2/de not_active Expired - Fee Related
- 2003-11-11 EP EP03025866A patent/EP1531159B1/de not_active Expired - Lifetime
- 2003-11-11 AT AT03025866T patent/ATE306497T1/de not_active IP Right Cessation
-
2004
- 2004-10-15 WO PCT/EP2004/011681 patent/WO2005044842A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP1531159B1 (de) | 2005-10-12 |
| DE60301891D1 (de) | 2006-02-23 |
| WO2005044842A1 (en) | 2005-05-19 |
| EP1531159A1 (de) | 2005-05-18 |
| DE60301891T2 (de) | 2006-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0306715A (pt) | Métodos para diagnóstico e tratamento de tumores | |
| DE60222910D1 (de) | Vaccinia virus für diagnose und behandlung von tumoren | |
| DE50210317D1 (de) | Peptid zur diagnose und therapie der alzheimer-demenz | |
| ATE345387T1 (de) | Verbindungen und verfahren für therapie und diagnose von lungenkrebs | |
| DE60039353D1 (de) | Verbindungen und verfahren für therapie und diagnose von lungenkrebs | |
| CY1114679T1 (el) | Συνθεσεις για διαγνωση και θεραπεια ασθενειων που συνδυαζονται με παρεκκλινουσα εκφραση φουτρινων (r-σπονδινων) | |
| DE60230046D1 (de) | Peptide, die atherosklerotische schädigungen binden | |
| AU2003242305A8 (en) | Hla-a24-restricted cancer antigen peptide | |
| DE60224419D1 (de) | Von igf-bindungsprotein stammendes peptid | |
| MX2007013626A (es) | Anticuerpos dirigidos contra el peptido beta amiloide y procedimientos que usan los mismos. | |
| ATE516304T1 (de) | Nrg-2 nukleinsäuren, polypeptide und diagnostische / therapeutische methoden | |
| MX344216B (es) | Productos geneticos expresados de forma diferencial en tumores y su uso. | |
| WO2005051315A3 (en) | On-demand cleavable linkers for radioconjugates for cancer imaging and therapy | |
| CY1116087T1 (el) | Πεπτιδια λαμβανομενα απο ανθρωπινη bplp πρωτεϊνη, πολυνουκλεοτιδια που κωδικοποιουν τα εν λογω πεπτιδια και αντισωματα κατευθυνομενα εναντι των εν λογω πεπτιδιων | |
| ATE435035T1 (de) | Verbesserte linker für radiopharmazeutische verbindungen | |
| ATE538811T1 (de) | Zytotoxizitätsvermittlung von zellen mit hinweisen auf oberflächenexpression von cd44 | |
| ATE306497T1 (de) | Peptid für die diagnose und therapie von tumoren | |
| ATE364315T1 (de) | Tgf-alpha polypeptide, funktionelle fragmente und verfahren zu ihrer anwendung | |
| IL207012A (en) | 28sgp medicinal product and 28sgp accent cancer treatment vaccine | |
| AR053385A1 (es) | Genes y proteinas novedosos de brachyspira hyodysenteriae y uso de los mismos para diagnostico y terapia | |
| ATE328899T1 (de) | Zellkernlokalisierendes protein für beta-catenin | |
| BRPI0413364A (pt) | proteases especìficas de ubiquitina | |
| ATE329027T1 (de) | Menschliches leucinereiche wiederholungen enthaltendes protein, vorwiegend im dünndarm exprimiert, hlrrsi1 | |
| ATE328082T1 (de) | Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen | |
| DE60108622D1 (de) | Arzneimittel zur anwendung bei tumorkrankheiten welches ro5-4864 und ein apoptoseauslöser enthält |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |